Low kidney volume is linked with higher chronic kidney disease risk, independent of eGFR and albuminuria. Kidney volume may improve classification of chronic kidney disease (CKD) risk, investigators ...

In the phase 2 MIRO-CKD trial, 12 weeks of balcinrenone combined with dapagliflozin reduced albuminuria compared with dapagliflozin alone added to standard of care in patients with stage 3-4 CKD.

Chronic Kidney Disease (CKD) signifies persistent kidney damage lasting over three months. The best indicator of kidney function is the Glomerular Filtration Rate (GFR), which measures how effectively ...

Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body. In ...

SAN DIEGO — Dapagliflozin provides significant benefits in the treatment of chronic kidney disease (CKD) even when initiated in patients with the most severe stages of the disease who are typically ...

A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...